Expanded access to NanO2 for serious conditions
Part of Brain & nervous system, Cancer, Heart & circulation clinical trials.
This program provides access to an investigational medicine called NanO2 for people with serious or life-threatening conditions who have no other treatment options. It aims to offer potential benefit when standard treatments have failed or are not available.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a serious or immediately life-threatening condition.
- You must have tried all other available treatments, or you cannot join a clinical trial.
- Your doctor must believe the potential benefits of NanO2 outweigh the risks.
- This treatment must not interfere with ongoing clinical trials that could support its approval.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests ONC206, a new targeted medicine, for diffuse midline gliomas (DMG) with a specific gene change (H3K27 altered) and for some other recurrent brain/spinal cord cancers. It is designed to find the right dose and see whether it can control or shrink tumors after initial treatment or when the cancer returns.
This trial tests a special oxygen formulation (NanO2) given soon after a stroke caused by a large artery blockage. It aims to see if extra oxygen can help protect the brain while doctors work to remove the clot.
This trial tests an experimental drug called NanO2 for people with mild respiratory distress who need a small amount of extra oxygen. The goal is to see if it can help improve oxygen levels.
This Phase 1 study tests whether injecting nitric oxide into certain solid tumors is safe and may help shrink tumors that cannot be removed with surgery. It includes adults with measurable, treatment-resistant skin or under-skin (cutaneous or subcutaneous) tumors and checks for side effects and early signs of benefit.
This trial tests whether giving nitric oxide gas through a breathing tube can improve oxygen levels in patients with severe obesity who are on a ventilator. It may help those whose lungs are struggling due to acute respiratory failure.
This trial tests a new treatment for recurrent glioblastoma using tiny magnetic particles (nanoparticles) that are heated to kill cancer cells. The particles are injected into the tumor, and then a magnetic field device heats them up. It's for people who have already tried standard therapy and whose tumor has come back.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.